Skip to main navigation Skip to search Skip to main content

Radiotherapy in Ewing's sarcoma: Results of the GPO studies CESS 81 and CESS 86

J. Dunst, R. Sauer, J. M.V. Burgers, R. Hawliczek, R. Kurten, R. P. Muller, M. Wannenmacher, H. Jurgens

Abstract

In CESS 81 the rate of local recurrences was high particularly in patients with radiation for local control. To improve the safety of local control, in the follow-up study CESS 86 chemotherapy for high risk patients was intensified. The combination of surgery with postoperative radiation was favoured when possible, local control was brought forward from week 18 to week 9, the dosis of postoperative radiotherapy was increased from 36 to 46 Gy, and a radiation planning center was established for centralized planning of radiotherapy on the basis of tumor extension at diagnosis. In addition patients with radiation were randomized for conventional fractionation or a scheme of accelerated split course hyperfractionation with simultaneous chemotherapy. Preliminary results of 76 CESS 86 patients (incl. pilot phase), show a lowered rate of local reccurrences compared to CESS 81: 6% local reccurrences in patients with resection and postoperative radiation and 15% local reccurrences in patients with radiation. With selection of patients with small and chemoresponsive tumors for radiotherapy no longer a disadvantage was seen for patients with radiotherapy concerning the safety of local control.

Original languageEnglish
JournalKlinische Padiatrie
Volume200
Issue number3
Pages (from-to)261-266
Number of pages6
ISSN0300-8630
DOIs
Publication statusPublished - 1988

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Radiotherapy in Ewing's sarcoma: Results of the GPO studies CESS 81 and CESS 86'. Together they form a unique fingerprint.

Cite this